This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Jun;9(3):185-7.

doi: 10.1007/s11892-009-0030-9.

ONTARGET: use of ramipril, telmisartan, or both in patients with high cardiovascular risks

HoWon Lee¹, Amgad N Makaryus, Samy I McFarlane

Affiliations

PMID: 19490818
DOI: 10.1007/s11892-009-0030-9

Comment

ONTARGET: use of ramipril, telmisartan, or both in patients with high cardiovascular risks

HoWon Lee et al. Curr Diab Rep. 2009 Jun.

. 2009 Jun;9(3):185-7.

doi: 10.1007/s11892-009-0030-9.

Authors

HoWon Lee¹, Amgad N Makaryus, Samy I McFarlane

Affiliation

¹ Division of Endocrinology, Department of Medicine, State University of New York-Downstate Medical Center, Kings County Hospital, Brooklyn, NY 11203, USA.

PMID: 19490818
DOI: 10.1007/s11892-009-0030-9

No abstract available

PubMed Disclaimer

Comment on

Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Clinical Trial.

References

1. N Engl J Med. 1992 Sep 3;327(10):669-77 - PubMed
1. J Card Fail. 2008 Apr;14(3):181-8 - PubMed
1. N Engl J Med. 1991 Aug 1;325(5):293-302 - PubMed
1. Ann Intern Med. 2008 Jan 1;148(1):30-48 - PubMed
1. Lancet. 2003 Sep 6;362(9386):767-71 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer